Valeant Pharmaceuticals: Now You Downgrade It?
June 23, 2016 at 11:14 AM EDT
Shares of Valeant Pharmaceuticals International ( VRX ) are trading near their lowest levels since 2010, which means an analyst out there must be downgrading the stock. JPMorgan's Chris Schott explain why they cut Valeant Pharmaceuticals International to Neutral from Overweight even as they remain bullish on specialty pharmaceutical companies like Endo International ( ENDP ), Allergan ( AGN ), Teva Pharmaceutical Industries ( TEVA ) and Mylan ( MYL ). They explain why:
